Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
Clinical trial NCT02155660 · COMPLETED
Trial details
- NCT number
- NCT02155660
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-25
- Primary completion
- 2018-04-09
- Enrollment
- 2255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.